Cameron John Reynolds - 08 Dec 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
President and CEO, Director
Signature
/s/ Cameron John Reynolds
Issuer symbol
VNRX
Transactions as of
08 Dec 2023
Net transactions value
+$6,700
Form type
4
Filing time
11 Dec 2023, 08:51:32 UTC
Previous filing
20 Oct 2023
Next filing
26 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Purchase $6,700 +10,000 +0.59% $0.6700 1,704,518 08 Dec 2023 Direct
holding VNRX Common Stock 1,007,718 08 Dec 2023 By Concord International, Inc. F1
holding VNRX Common Stock 34,076 08 Dec 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.